Clinical trial NCT00681837: Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France
Official title: Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Gastroesophageal Reflux
Keywords: gastroesophageal reflux
prevalence
childhood
France
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-05-21
Enrollment: 2500
Sex: ALL
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: children recruited by both GPs and paediatricians

Brief summary: The purpose of this study is to assess prevalence of gastrooesophageal reflux during childhood and teenage years in France and to describe patients'symptoms and gastrooesophageal reflux management


Eligibility criteria: Inclusion Criteria:

* children from 0 to 17years old seen in consultation

Exclusion Criteria:

Primary outcomes:
measure: assess prevalence of gastrooesophageal reflux during childhood and teenage years in France, particularly 0-1 year-old prevalence and 1-11 year-old prevalence
timeFrame: At the end of the study
Secondary outcomes:
measure: describe patients'symptoms and gastrooesophageal reflux management
timeFrame: At the end of the study
Other outcomes:
Locations:
city: Hefei
country: China
facility: Research Site
state: Anhui
city: Chongqing
country: China
facility: Research Site
state: Chongqing
city: Fuzhou
country: China
facility: Research Site
state: Fujian
city: Guangzhou
country: China
facility: Research Site
state: Guangdong
city: Shenzhen
country: China
facility: Research Site
state: Guangdong
city: Xiamen
country: China
facility: Research Site
state: Guangdong
city: Zhongshan
country: China
facility: Research Site
state: Guangdong
city: Zhengzhou
country: China
facility: Research Site
state: Henan
city: Wuhan
country: China
facility: Research Site
state: Hubei
city: Changsha
country: China
facility: Research Site
state: Hunan
city: Nanjing
country: China
facility: Research Site
state: Jiangsu
city: Suzhou
country: China
facility: Research Site
state: Jiangsu
city: Wuxi
country: China
facility: Research Site
state: Jiangsu
city: Nanchang
country: China
facility: Research Site
state: Jiangxi
city: Jinan
country: China
facility: Research Site
state: Shandong
city: Qingdao
country: China
facility: Research Site
state: Shandong
city: Shanghai
country: China
facility: Research Site
state: Shanghai
city: Taiyuan
country: China
facility: Research Site
state: Shanxi
city: Xi'an
country: China
facility: Research Site
state: Shanxi
city: Chengdu
country: China
facility: Research Site
state: Sichuan
city: Kunming
country: China
facility: Research Site
state: Yunnan
city: Hangzhou
country: China
facility: Research Site
state: Zhejiang
city: Ningbo
country: China
facility: Research Site
state: Zhejiang
city: Rui'an
country: China
facility: Research Site
state: Zhejiang
city: Wenzhou
country: China
facility: Research Site
state: Zhejiang
Study officials:
affiliation: CHRU Lille - France
name: Frédéric GOTTRAND
role: STUDY_CHAIR
affiliation: TNS Healthcare 92120 Montrouge - France
name: Geneviève BONNELYE
role: PRINCIPAL_INVESTIGATOR
References: